loadpatents
name:-0.033291101455688
name:-0.01997709274292
name:-0.0032260417938232
O'Brien; Michael Alistair Patent Filings

O'Brien; Michael Alistair

Patent Applications and Registrations

Patent applications and USPTO patent grants for O'Brien; Michael Alistair.The latest application filed is for "cgrp antagonist compounds".

Company Profile
7.26.34
  • O'Brien; Michael Alistair - Cambridge GB
  • O'Brien; Michael Alistair - Welwyn Garden City GB
  • O'Brien; Michael Alistair - Welwyn Garden GB
  • O'Brien; Michael Alistair - Hertz GB
  • O'Brien; Michael Alistair - Hitchin GB
  • O'Brien; Michael Alistair - Herts GB
  • O'Brien; Michael Alistair - Hertfordshire GB
  • O'Brien; Michael Alistair - Hitchen GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cgrp Antagonist Compounds
App 20220306651 - Brown; Giles Albert ;   et al.
2022-09-29
Cgrp Antagonist Compounds
App 20220251110 - Brown; Giles Albert ;   et al.
2022-08-11
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor
Grant 10,961,225 - Brown , et al. March 30, 2
2021-03-30
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor
App 20200325118 - Brown; Giles Albert ;   et al.
2020-10-15
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor
Grant 10,689,368 - Brown , et al.
2020-06-23
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor
App 20190337925 - Brown; Giles Albert ;   et al.
2019-11-07
Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists
Grant 10,385,039 - Brown , et al. A
2019-08-20
Bicyclic Aza Compounds As Muscarnic M1 Receptor And/or M4 Receptor Antagonists
App 20190112294 - Brown; Giles Albert ;   et al.
2019-04-18
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists
Grant 10,196,380 - Brown , et al. Fe
2019-02-05
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor Agonists
App 20180179184 - Brown; Giles Albert ;   et al.
2018-06-28
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists
Grant 9,926,297 - Brown , et al. March 27, 2
2018-03-27
Hydroxybenzamide derivatives and their use as inhibitors of HSP90
Grant 9,914,719 - Chessari , et al. March 13, 2
2018-03-13
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor Agonists
App 20170240530 - Brown; Giles Albert ;   et al.
2017-08-24
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists
Grant 9,670,183 - Brown , et al. June 6, 2
2017-06-06
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor Agonists
App 20170015650 - Brown; Giles Albert ;   et al.
2017-01-19
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
Grant 9,051,278 - Berdini , et al. June 9, 2
2015-06-09
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators
App 20140371213 - BERDINI; Valerio ;   et al.
2014-12-18
Bicyclic heterocyclic compounds as FGFR inhibitors
Grant 8,895,745 - Berdini , et al. November 25, 2
2014-11-25
Substituted Benzylamine Compounds, Their Use In Medicine, And In Particular The Treatment Of Hepatitis C Virus (hcv) Infection
App 20140288040 - Woodhead; Andrew James ;   et al.
2014-09-25
Pharmaceutical compounds
Grant 8,779,132 - Congreve , et al. July 15, 2
2014-07-15
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
Grant 8,779,147 - Berdini , et al. July 15, 2
2014-07-15
Benzimidazole Derivatives And Their Use As Protein Kinase Inhibitors
App 20140010892 - BERDINI; Valerio ;   et al.
2014-01-09
Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90
Grant 8,530,469 - Chessari , et al. September 10, 2
2013-09-10
Imidazo[1,2-a]pyridine compounds for use in treating cancer
Grant 8,513,276 - Berdini , et al. August 20, 2
2013-08-20
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators
App 20120213791 - BERDINI; Valerio ;   et al.
2012-08-23
Dihydroxyphenyl isoindolylmethanones
Grant 8,106,057 - Chessari , et al. January 31, 2
2012-01-31
Hydroxybenzamide derivatives and their use as inhibitors of HSP90
Grant 8,101,648 - Chessari , et al. January 24, 2
2012-01-24
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
Grant 8,080,666 - Berdini , et al. December 20, 2
2011-12-20
Benzimidazole Derivatives And Their Use As Protein Kinase Inhibitors
App 20110224203 - BERDINI; Valerio ;   et al.
2011-09-15
Benzimidazole derivatives and their use as protein kinase inhibitors
Grant 7,977,477 - Berdini , et al. July 12, 2
2011-07-12
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators
App 20110003799 - BERDINI; Valerio ;   et al.
2011-01-06
Dihydroxyphenyl Isoindolylmethanones
App 20100286167 - Chessari; Gianni ;   et al.
2010-11-11
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
Grant 7,825,140 - Berdini , et al. November 2, 2
2010-11-02
Dihydroxyphenyl isoindolymethanones
Grant 7,754,725 - Chessari , et al. July 13, 2
2010-07-13
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
Grant 7,745,638 - Berdini , et al. June 29, 2
2010-06-29
Pyrazole Derivatives As That Modulate The Activity Of Cdk, Gsk And Aurora Kinases
App 20100160324 - Berdini; Valerio ;   et al.
2010-06-24
Pharmaceutical Compounds
App 20100152184 - Congreve; Miles Stuart ;   et al.
2010-06-17
Bicyclic Heterocyclic Compounds as FGFR Inhibitors
App 20100120761 - Berdini; Valerio ;   et al.
2010-05-13
Compounds
App 20100093718 - Berdini; Valerio ;   et al.
2010-04-15
Pyrimidine Derivatives As HSP90 Inhibitors
App 20090215777 - Chessari; Gianni ;   et al.
2009-08-27
Hydroxybenzamide derivatives and their use as inhibitors of HSP90
App 20090215772 - Chessari; Gianni ;   et al.
2009-08-27
Thiazole And Isothiazole Derivatives That Modulate The Activity Of CDK, GSK And Aurora Kinases
App 20080312223 - Berdini; Valerio ;   et al.
2008-12-18
Pharmaceutical Compounds
App 20080306054 - Chessari; Gianni ;   et al.
2008-12-11
Pyrazole Derivatives for the Inhibition of CDK'S and GSK'S
App 20080306069 - Wyatt; Paul Graham ;   et al.
2008-12-11
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators
App 20080269207 - Berdini; Valerio ;   et al.
2008-10-30
3,4-disubstituted 1h-pyrazole Compounds And Their Use As Cyclin Dependent Kinase And Glycogen Synthase Kinase-3 Modulators
App 20080200509 - Berdini; Valerio ;   et al.
2008-08-21
Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's
App 20080194562 - Wyatt; Paul Graham ;   et al.
2008-08-14
Pharmaceutical Compounds
App 20080167309 - Berdini; Valerio ;   et al.
2008-07-10
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
Grant 7,385,059 - Berdini , et al. June 10, 2
2008-06-10
3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors
App 20080004270 - Gill; Adrian Liam ;   et al.
2008-01-03
Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90
App 20070259871 - Chessari; Gianni ;   et al.
2007-11-08
Dihydroxyphenyl Isoindolylmethanones
App 20070259886 - Chessari; Gianni ;   et al.
2007-11-08
Benzimidazole derivatives and their use as protein kinases inhibitors
App 20070135477 - Berdini; Valerio ;   et al.
2007-06-14
Pharmaceutical compounds
App 20070105900 - Berdini; Valerio ;   et al.
2007-05-10
3,4-Disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
App 20060194843 - Berdini; Valerio ;   et al.
2006-08-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed